儿童青少年高血压筛查与管理临床实践指南
主要变更包括用「血压升高」替代「高血压前期」、基于正常体重儿童的新血压表、简化筛查表与青少年血压分类、扩大动态血压监测应用、修订超声心动图检查时机及左心室肥厚定义。
要点
- 用「血压升高」替代「高血压前期」,并采用基于正常体重儿童的新血压百分位表。
- 青少年(≥13岁)血压分类与成人指南对齐,简化筛查表识别需进一步评估者。
- 动态血压监测在诊断和管理中作用扩大,超声心动图一般仅推荐在启动药物治疗前进行。
核心结论
- 指南更新了儿童青少年高血压的筛查、诊断评估和管理推荐,强调以患者和家庭为中心的照护。
主要发现
- 指南包含30条关键行动声明和27条附加推荐,每条关键行动声明均包含证据等级、获益-危害关系和推荐强度。
关键数值与推荐
- 用「血压升高」替代「高血压前期」。
- 采用基于正常体重儿童的新规范血压表。
- 提供简化筛查表以识别需要进一步评估的血压。
- 对≥13岁青少年采用与即将发布的AHA和ACC成人血压指南一致的简化分类。
- 推荐仅在预防保健访视时进行筛查血压测量。
临床怎么用
- 在预防保健访视时使用简化筛查表识别血压升高儿童,对异常者按 streamlined 推荐进行初始评估和管理。
- 对≥13岁青少年采用与成人指南一致的血压分类,合理应用动态血压监测辅助诊断。
- 新诊断高血压患儿在启动药物治疗前考虑超声心动图评估,并参照修订后的左心室肥厚定义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
These pediatric hypertension guidelines are an update to the 2004 "Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents." Significant changes in these guidelines include (1) the replacement of the term "prehypertension" with the term "elevated blood pressure," (2) new normative pediatric blood pressure (BP) tables based on normal-weight children, (3) a simplified screening table for identifying BPs needing further evaluation, (4) a simplified BP classification in adolescents ≥13 years of age that aligns with the forthcoming American Heart Association and American College of Cardiology adult BP guidelines, (5) a more limited recommendation to perform screening BP measurements only at preventive care visits, (6) streamlined recommendations on the initial evaluation and management of abnormal BPs, (7) an expanded role for ambulatory BP monitoring in the diagnosis and management of pediatric hypertension, and (8) revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy. These guidelines include 30 Key Action Statements and 27 additional recommendations derived from a comprehensive review of almost 15 000 published articles between January 2004 and July 2016. Each Key Action Statement includes level of evidence, benefit-harm relationship, and strength of recommendation. This clinical practice guideline, endorsed by the American Heart Association, is intended to foster a patient- and family-centered approach to care, reduce unnecessary and costly medical interventions, improve patient diagnoses and outcomes, support implementation, and provide direction for future research.
引用
- Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017. PMID: 28827377. doi:10.1542/peds.2017-1904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。